
Book Description
This digital document is an article from Emerging Infectious Diseases, published by U.S. National Center for Infectious Diseases on February 1, 2003. The length of the article is 1441 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation Details
Title: Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar. (Letters).
Author: Sabai Phyu
Publication: Emerging Infectious Diseases (Refereed)
Date: February 1, 2003
Publisher: U.S. National Center for Infectious Diseases
Volume: 9 Issue: 2 Page: 274(3)Distributed by Thompson Gale
Excerpt. © Reprinted by permission. All rights reserved.
To the Editor: Spread of drug-resistant tuberculosis (TB) and disastrous rates of HIV-TB co-infection pose serious threats to TB-control programs around the world (1). The World Health Organization/International Union Against Tuberculosis and Lung Diseases urges all national TB programs to practice the Directly Observed Treatment-Short Course (DOTS) strategy as well as to closely monitor the patterns and trends of anti-TB drug resistance (2). Such data allow an assessment of the quality of TB control, help forecast future trends of drug-resistance, and serve as guidelines for suitable therapy.